Nantahala Capital Partners Limited Partnership 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-20 4:31 pm Sale |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 3,009,021 2.760% |
-4,878,815 (-61.85%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 7,887,836 7.760% |
5,766,083 (+271.76%) |
Filing |
| 2024-02-02 8:32 pm Purchase |
2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 2,121,753 6.100% |
2,121,753 (New Position) |
Filing |